Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
NPJ Breast Cancer|August 4, 2022
The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancerEdoardo Isnaldi, François Richard, Maxim De Schepper, et al.
BMC Cancer|August 7, 2021
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trialAlex De Caluwé, Laurence Buisseret, Philip Poortmans, et al.
EMBO Molecular Medicine|June 2, 2017
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclibEric Raspé, Katia Coulonval, Jaime M Pita, et al.
Cancer Letters|February 25, 2019
BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancerCinzia Solinas, Diane Marcoux, Soizic Garaud, et al.
Ebiomedicine|December 24, 2018
FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancerPushpamali De Silva, Soizic Garaud, Cinzia Solinas, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
British Journal of Cancer|March 23, 2019
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomesHervé Bonnefoi, Gaetan MacGrogan, Coralie Poncet, et al.
Plos One|January 26, 2011
HER2-positive circulating tumor cells in breast cancerMichail Ignatiadis, Françoise Rothé, Carole Chaboteaux, et al.
JCI Insight|August 14, 2019
Tumor infiltrating B-cells signal functional humoral immune responses in breast cancerSoizic Garaud, Laurence Buisseret, Cinzia Solinas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic gradeSherene Loi, Benjamin Haibe-Kains, Christine Desmedt, et al.
Pageof 16